Chymotrypsinogen B2 (CTRB2)

Homo sapiens — UniProt Q6GPI1

Gene: CTRB2Homo sapiensSwissProt reviewed

About Chymotrypsinogen B2

Chymotrypsinogen B2 (CTRB2) is a protein from Homo sapiens identified by UniProt accession Q6GPI1, 263 residues long. MolForge cross-references it against 0 known binders and 48 disease associations.

Target properties

Protein nameChymotrypsinogen B2
UniProt accessionQ6GPI1
GeneCTRB2
OrganismHomo sapiens
Length263 residues
Molecular weight—
EC numbers—
Target classUNCLASSIFIED
Subcellular location—
Keywords—

Druggability

Target tractability assessment (Open Targets + pocket analysis). No approved drug

Druggability tierMEDIUM
Druggability score—
Pocket score—
Max clinical phase—

Disease associations (48)

Diseases linked to this target (Open Targets).

  • type 2 diabetes mellitus · score 0.31
  • diabetes mellitus · score 0.28
  • neurodegenerative disease · score 0.27
  • blood protein measurement · score 0.25
  • breast adenocarcinoma · score 0.22
  • type 1 diabetes mellitus · score 0.21
  • age-related macular degeneration · score 0.20
  • wet macular degeneration · score 0.19
  • atrophic macular degeneration · score 0.19
  • Drugs used in diabetes use measurement · score 0.19

3D Structure (1)

Experimental (PDB) and predicted (AlphaFold) structures for this protein.

StructureSourceMethodMean pLDDTResolution (Å)
AF-Q6GPI1-F1alphafoldPREDICTED91.90—

Amino-acid sequence (263 residues)

MAFLWLLSCW ALLGTTFGCG VPAIHPVLSG LSRIVNGEDA VPGSWPWQVS LQDKTGFHFC GGSLISEDWV VTAAHCGVRT SDVVVAGEFD QGSDEENIQV LKIAKVFKNP KFSILTVNND ITLLKLATPA RFSQTVSAVC LPSADDDFPA GTLCATTGWG KTKYNANKTP DKLQQAALPL LSNAECKKSW GRRITDVMIC AGASGVSSCM GDSGGPLVCQ KDGAWTLVGI VSWGSRTCST TTPAVYARVA KLIPWVQKIL AAN

Explore Chymotrypsinogen B2 with MolForge

Find binders, run structure-based screening, and map this target across diseases and approved drugs with our AI-powered platform.

Browse all targets

Quick facts

UniProtQ6GPI1
GeneCTRB2
OrganismHomo sapiens
Length263
Binders0
Diseases48
View on UniProt